The clinical efficacy is real, the safety profile is well-characterised, and the supply chain is now properly cold-chain-audited
Medications like Semaglutide (Wegovy, Ozempic) or Tirzepatide (Mounjaro, Zepbound) activate GLP-1 receptors to: Delay stomach emptying Reduce hunger levels Encourage a sense of fullness Keep blood sugar in balance This helps create a calorie gap, which supports gradual and safe fat loss when paired with healthy habits and doctor oversight
3 After roughly 18 months, participants lost about 10 percent of body weight, and average total testosterone increased by 18 percent, suggesting that weight reduction from GLP-1 therapy may help reverse obesity-related low testosterone
Based on the current body of research, the most frequently reported mild side effect is localized irritation at the administration site
In trials and patient reviews, some people noted that it helped them lose weight and control their diabetes
Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide